OREXO AB |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 16.9 SEK | +2.67% |
|
+7.10% | +9.31% |
| Apr. 17 | Orexo Expands, Extends US Patent for Nasal Anaphylaxis Treatment | MT |
| Apr. 17 | Orexo Extends Patent Protection for Its Nasal Epinephrine Powder Product OX640 in the US | CI |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Bullish | Bullish |
| Resistance | 17.50 | 17.50 | 19.02 |
| Spread/Res. | -3.43% | -3.43% | -11.15% |
| Spread/Supp. | +7.10% | +7.10% | +29.11% |
| Support | 15.78 | 15.78 | 13.09 |
Technical Rankings Surperformance
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- ORX Stock
- Charts Orexo AB
